These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7694634

  • 21. All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Mounier N, Gisselbrecht C, Brière J, Haioun C, Feugier P, Offner F, Recher C, Stamatoullas A, Morschhauser F, Macro M, Thieblemont C, Sonet A, Fabiani B, Reyes F, Groupe d'Etude des Lymphomes de l'Adulte.
    Ann Oncol; 2004 Dec; 15(12):1790-7. PubMed ID: 15550584
    [Abstract] [Full Text] [Related]

  • 22. Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.
    Morel P, Gaulard P, Gisselbrecht C, Ferme C, Salles G, Tilly H, Brière J, Copin MC, Lederlin P, Hermine O, Theate I, Haioun C, Mounier N, Groupe d'Etude des Lymphomes de l'Adulte.
    Ann Oncol; 2008 Mar; 19(3):560-5. PubMed ID: 18096567
    [Abstract] [Full Text] [Related]

  • 23. Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
    Oksenhendler E, Gerard L, Dubreuil ML, Levy Y, Matheron S, Cazals-Hatem D, Chevret S, Clauvel JP.
    Leuk Lymphoma; 2000 Sep; 39(1-2):87-95. PubMed ID: 10975387
    [Abstract] [Full Text] [Related]

  • 24. ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.
    Fermé C, Thomas J, Brice P, Casasnovas O, Vranovsky A, Bologna S, Lugtenburg PJ, Bouabdallah R, Carde P, Sebban C, Eghbali H, Salles G, van Imhoff GW, Thyss A, Noordijk EM, Reman O, Lybeert MLM, Janvier M, Spina M, Audhuy B, Raemaekers JMM, Delarue R, Anglaret B, de Weerdt O, Marjanovic Z, Tersteeg RJHA, de Jong D, Brière J, Henry-Amar M, European Organisation for Research and Treatment of Cancer Lymphoma Group, and, Groupe d'Étude des Lymphomes de l'Adulte.
    Eur J Cancer; 2017 Aug; 81():45-55. PubMed ID: 28601705
    [Abstract] [Full Text] [Related]

  • 25. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
    Gisselbrecht C, Oksenhendler E, Tirelli U, Lepage E, Gabarre J, Farcet JP, Gastaldi R, Coiffier B, Thyss A, Raphael M.
    Am J Med; 1993 Aug; 95(2):188-96. PubMed ID: 7689296
    [Abstract] [Full Text] [Related]

  • 26. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma.
    McMaster ML, Johnson DH, Greer JP, Wolff SN, Hildreth CR, Greco FA, Hainsworth JD.
    Cancer; 1991 Mar 15; 67(6):1487-92. PubMed ID: 1705861
    [Abstract] [Full Text] [Related]

  • 27. P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL).
    Bertini M, Freilone R, Vitolo U, Botto B, Pizzuti M, Gavarotti P, Levis A, Orlandi E, Orsucci L, Pini M.
    Ann Oncol; 1994 Dec 15; 5(10):895-900. PubMed ID: 7535080
    [Abstract] [Full Text] [Related]

  • 28. Non-Hodgkin's lymphoma associated with human immunodeficiency virus: treatment with LNH 84 regimen in a selected group of patients.
    Gisselbrecht C, Oksenjendler E, Tirelli U, Gabarre J, Gastaldi R, Farcet JP, Thyss A, Coiffier B, Raphael M, Lepage E.
    Leukemia; 1992 Dec 15; 6 Suppl 3():10S-11S. PubMed ID: 1376380
    [No Abstract] [Full Text] [Related]

  • 29. Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
    Herbrecht R, Damonte JC, Dufour P, Maloisel F, Liu KL, Ortiz S, Bergerat JP, Oberling F.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 1):7-10. PubMed ID: 1384135
    [Abstract] [Full Text] [Related]

  • 30. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D, Sebban C, Gaulard P, Coiffier B, Tilly H, Cazals D, Boehn A, Casasnovas RO, Bouabdallah R, Jaubert J, Ferrant A, Diebold J, de Mascarel A, Gisselbrecht C.
    J Clin Oncol; 1997 Apr 15; 15(4):1654-63. PubMed ID: 9193366
    [Abstract] [Full Text] [Related]

  • 31. Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
    Jackson GH, Lennard AL, Taylor PR, Carey P, Angus B, Lucraft H, Evans RG, Proctor SJ.
    Br J Cancer; 1994 Sep 15; 70(3):501-5. PubMed ID: 7521662
    [Abstract] [Full Text] [Related]

  • 32. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.
    Ribrag V, Koscielny S, Bosq J, Leguay T, Casasnovas O, Fornecker LM, Recher C, Ghesquieres H, Morschhauser F, Girault S, Le Gouill S, Ojeda-Uribe M, Mariette C, Cornillon J, Cartron G, Verge V, Chassagne-Clément C, Dombret H, Coiffier B, Lamy T, Tilly H, Salles G.
    Lancet; 2016 Jun 11; 387(10036):2402-11. PubMed ID: 27080498
    [Abstract] [Full Text] [Related]

  • 33. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
    Martelli M, Vignetti M, Zinzani PL, Gherlinzoni F, Meloni G, Fiacchini M, De Sanctis V, Papa G, Martelli MF, Calabresi F, Tura S, Mandelli F.
    J Clin Oncol; 1996 Feb 11; 14(2):534-42. PubMed ID: 8636768
    [Abstract] [Full Text] [Related]

  • 34. Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84).
    Colombat P, Guilhot F, Bordesoule D, Renou P, Benz-Lemoine E, Fouillard L, Drouet M, Tanzer J, Lamagnere JP.
    Haematologica; 1991 Feb 11; 76(6):479-84. PubMed ID: 1726492
    [Abstract] [Full Text] [Related]

  • 35. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
    Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N.
    J Clin Oncol; 1989 Aug 11; 7(8):1018-26. PubMed ID: 2474057
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).
    Morschhauser F, Mounier N, Sebban C, Brice P, Solal-Celigny P, Tilly H, Feugier P, Fermé C, Copin MC, Lamy T.
    Cancer; 2010 Sep 15; 116(18):4299-308. PubMed ID: 20549824
    [Abstract] [Full Text] [Related]

  • 37. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    McMaster ML, Greer JP, Wolff SN, Johnson DH, Greco FA, Stein RS, Cousar JB, Flexner JM, Hainsworth JD.
    Cancer; 1991 Jul 15; 68(2):233-41. PubMed ID: 1712662
    [Abstract] [Full Text] [Related]

  • 38. Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Ghesquières H, Ferlay C, Sebban C, Perol D, Bosly A, Casasnovas O, Reman O, Coiffier B, Tilly H, Morel P, Van den Neste E, Colin P, Haioun C, Biron P, Blay JY.
    Ann Oncol; 2010 Apr 15; 21(4):842-850. PubMed ID: 19914958
    [Abstract] [Full Text] [Related]

  • 39. CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
    Cameron DA, White JM, Proctor SJ, Prescott RJ, Leonard RC, Angus B, Cook MK, Dawes PJ, Dawson AA, Evans RG, Galloway MJ, Harris AL, Heppleston A, Horne CH, Krajewski AS, Lennard AL, Lessells AM, Lucraft HH, MacGillivray JB, Mackie MJ, Parker AC, Roberts JT, Taylor PR, Thompson WD.
    Eur J Cancer; 1997 Jul 15; 33(8):1195-201. PubMed ID: 9301442
    [Abstract] [Full Text] [Related]

  • 40. Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
    Bosly A, Lepage E, Coiffier B, Fillet G, Herbrecht R, Divine M, Dupriez B, Nouvel C, Deconninck E, Tilly H, Bordessoule D, Gaulard P, Gisselbrecht C, GELA.
    Hematol J; 2001 Jul 15; 2(4):279-85. PubMed ID: 11920261
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.